Fundz

Stratum Biosciences Raises $2M in Seed Funding to Scale AI-Powered Skin Biology Platform with Backing from Harvard Business School Angels and Skin Angels.

PRIVATEMar 30, 2026

Amount Raised

$2 Million

Round Type

Seed

BiotechnologyHealth CareArtificial Intelligence

Investors

Skin AngelsHarvard Business School Alumni Angels Of Greater New York

Description

Stratum Biosciences, a NYC-based biotechnology company, closed a $2M seed funding. The funds will be used to scale its AI-powered skin biology discovery platform and build partnerships in the field. Major backers included the Harvard Business School Alumni Angels and Skin Angels. The company is focused on accelerating product development in dermatology research.

Quick answer

Stratum Biosciences raised $2 Million in a Seed round, dated March 30, 2026. Investors: Skin Angels and Harvard Business School Alumni Angels Of Greater New York.

How much did Stratum Biosciences raise?
Stratum Biosciences raised $2 Million in a Seed round on March 30, 2026.
Who invested in Stratum Biosciences?
Skin Angels and Harvard Business School Alumni Angels Of Greater New York are named as investors in this round.
What does Stratum Biosciences do?
Stratum Biosciences is a biotechnology company based in NYC, focusing on artificial intelligence and dermatology research.
Who are the decision-makers at Stratum Biosciences?
Fundz holds 1 contact at Stratum Biosciences, including the Chief Executive Officer, Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Stratum Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Navidence raised an undisclosed amount on May 5, 2026.
  • dehaze raised $3.7M (Seed) on April 28, 2026.
  • Dehaze GmbH raised $3.7M (Seed) on April 28, 2026.
  • SquareMind raised $18M (Series A) on April 27, 2026.
  • Almanac Health raised $10M (Seed) on April 23, 2026.
  • Bioxtreme raised $15M (Funding Round) on April 21, 2026.

Who to call at Stratum Biosciences, and when

A new round usually means Stratum Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Stratum Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Stratum Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Stratum Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Stratum Biosciences

About

Stratum Biosciences is a biotechnology company based in NYC, focusing on artificial intelligence and dermatology research. Co-founded in 2024, it leverages a proprietary AI platform and over 200,000 real tissue samples to accelerate the development of novel active ingredients and formulations for skincare products. The company has partnered with global CPG leaders to create innovative formulations targeting skincare needs. Its SkinSync™ platform provides significant insights into skin biology, aiming to revolutionize skincare and dermatology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Stratum Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRoss P., Chief Executive Officer, Co-FounderSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Stratum Biosciences's next move

See what Strategic adds

Stratum Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.